Journal of Urology

Papers
(The median citation count of Journal of Urology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Editorial Comment387
Editorial Comment257
Reflections on Diversity, Equity, and Inclusion in Medical Publishing: The Journal of Urology ® HEAD Table237
MP04-06 NOVEL CONTIGUOUS GENE DISORDER OF PKD1 , TSC2 AND NTHL1 LEADING TO CORRESPONDING KIDNEY DISEASES AN229
Kidney Cancer: Basic Research & Pathophysiology I (MP04)198
Assessing “Spin” in Urology Randomized Controlled Trials With Statistically Nonsignificant Primary Outcomes. Letter.154
Reply by Authors153
Reply by Authors146
V04-12 ROBOT-ASSISTED PARTIAL NEPHRECTOMY USING INTRA-ARTERIAL RENAL HYPOTHERMIA FOR HIGHLY COMPLEX ENDOPHYTIC OR HILAR TUMORS124
Multimodal Biomarkers That Predict the Presence of Gleason Pattern 4: Potential Impact for Active Surveillance. Letter.123
Editorial Comment121
MP78-19 PREOPERATIVE BLADDER MECHANICS FORECAST INDIVIDUALIZED ARTIFICIAL URINARY SPHINCTER LONGEVITY119
Editorial Comment114
Selecting Patients with Favorable Risk, Grade Group 2 Prostate Cancer for Active Surveillance—Does Magnetic Resonance Imaging Have a Role?102
PD60-08 OUTCOMES OF SALVAGE ROBOTIC-ASSISTED RADICAL PROSTATECTOMY COMPARING PATIENTS WITH PRIMARY FOCAL THERAPY VERSUS WHOLE GLAND ABLATION: A MULTICENTRIC COLLABORATIVE DATA98
MP20-07 NPTX1 IS A NOVEL SERUM BIOMARKER INDUCED BY ARPI TREATED PROSTATE CANCER AND ENRICHED IN LINEAGE PLASTICITY WITH BRN2 HIGH88
PD34-03 INTRAOPERATIVE TRANEXAMIC ACID IN RADICAL CYSTECTOMY: IMPACT ON BLEEDING, THROMBOEMBOLISM, AND CANCER-SPECIFIC SURVIVAL83
Letter: Miniaturized Percutaneous Nephrolithotomy With Vacuum-Assisted Access Sheaths for Treatment of Nephrolithiasis76
Reply: The AUA/SUFU Guideline on the Diagnosis and Treatment of Idiopathic Overactive Bladder70
Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome. Reply.66
LBA02-07 SEX-DEPENDENT DISTRIBUTION OF PATHOGENIC GERMLINE VARIANTS IN BLADDER CANCER: A POPULATION-BASED ANALYSIS OF 400,000 INDIVIDUALS60
Expression of Concern: Lymph Node Mapping in Patients with Penile Cancer Undergoing Pelvic Lymph Node Dissection59
Expression of Concern: Sperm DNA Damage and Semen Quality Impairment After Treatment With Selective Serotonin Reuptake Inhibitors Detected Using Semen Analysis and Sperm Chromatin Structure Assay57
Expression of Concern: Penile Fractures: Evaluation, Therapeutic Approaches and Long-Term Results56
Expression of Concern: Ureterovaginal Fistula After Vaginal Delivery55
Expression of Concern: Comparison of Vitamin E and Propionyl-L-Carnitine, Separately or in Combination, in Patients With Early Chronic Peyronie’s Disease: A Double-Blind, Placebo Controlled, Randomize54
Gemcitabine Versus Bacillus Calmette-Guérin for Intravesical Therapy in Treatment-Naïve Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer48
PD43-07 CLINICAL CHARACTERISTICS ASSOCIATED WITH HIGH-RISK CANCER-PREDISPOSITION GERMLINE MUTATIONS IN PATIENTS WITH UROTHELIAL CARCINOMA: IMPLICATIONS FOR GENETIC TESTING48
MP38-07 UPGRADING ON PER PROTOCOL VS FOR CAUSE SURVEILLANCE PROSTATE BIOPSIES: AN OPPORTUNITY TO DECREASING THE BURDEN OF ACTIVE SURVEILLANCE47
PD26-08 ERECTILE DYSFUNCTION IN MEN WITH PREDIABETES AND TYPE 2 DIABETES: THE DIABETES PREVENTION PROGRAM OUTCOMES STUDY (DPPOS)46
PD54-05 STENT OMISSION IN PRESTENTED PATIENTS UNDERGOING URETEROSCOPY DECREASES UNPLANNED HEALTHCARE UTILIZATION46
MP13-08 IMPACT OF PATIENT, SURGICAL, AND PERIOPERATIVE FACTORS ON DISCHARGE DISPOSITION AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER46
MP62-03 CONFIRMATORY TESTING OUTCOMES IN ACTIVE SURVEILLANCE: RESULTS FROM THE MICHIGAN UROLOGICAL SURGERY IMPROVEMENT COLLABORATIVE (MUSIC)46
MP45-10 PERSPECTIVES ON THE ROLE OF BIOPSY FOR MANAGEMENT OF T1 RENAL MASSES: RESULTS FROM TWO QUALITY IMPROVEMENT COLLABORATIVES46
MP30-10 UROLOGICAL CANCERS DURING COVID-19: ANALYSES OF SHORT-TERM OUTCOMES FROM THE COVIDSURG-CANCER STUDY45
PD11-06 BASELINE PSA BELOW 1.0 NG/ML, AND THEN? VERIFICATION OF THE EAU 2021 POSITION AND RECOMMENDATION ON RISK-ADAPTED EARLY DETECTION USING ERSPC ROTTERDAM DATA WITH MORE THAN 20 YEARS OF DETAILED 45
MP62-14 THE INFLUENCE OF MAGNETIC RESONANCE IMAGING, GENOMIC CLASSIFIERS, AND POST-MAGNETIC RESONANCE IMAGING BIOPSY RESULTS ON SHARED-DECISION MAKING IN NEWLY DIAGNOSED FAVORABLE RISK PROSTATE CANCER45
PD26-10 COMPARISON OF INTRAVESICAL THERAPY AND SURGERY AS TREATMENT OPTIONS FOR RECURRENT BLADDER CANCER (CISTO): UPDATE ON AN ONGOING MULTICENTER PRAGMATIC STUDY42
MP33-08 OPIOID PRESCRIBING PATTERNS AND POST-PROSTATECTOMY READMISSION41
PD11-03 SURGEON SKILL IS ASSOCIATED WITH POSITIVE SURGICAL MARGINS IN ROBOT-ASSISTED PARTIAL NEPHRECTOMY: RESULTS OF A VIDEO-BASED EVALUATION40
MP19-04 INFLUENCE OF INDIVIDUAL UROLOGISTS AND RADIOLOGISTS ON VARIATION IN MRI GUIDED PROSTATE FUSION BIOPSY OUTCOMES39
PD47-12 DOES ANESTHESIA TYPE MATTER IN SHOCKWAVE LITHOTRIPSY?39
Male Infertility38
Editorial Comment38
Cost-Effectiveness Analysis of Pembrolizumab for Bacillus Calmette-Guérin-Unresponsive Carcinoma In Situ of the Bladder38
Mixed Gonadal Dysgenesis: A Narrative Literature Review and Clinical Primer for the Urologist37
An Automated Electronic Health Record Score to Estimate Length of Stay and Readmission in Patients Undergoing Radical Cystectomy for Bladder Cancer37
Urologic Oncology: Prostate Cancer36
Reply by Authors35
A Multi-Institutional Study of Magnetic Resonance/Ultrasound Fusion–Guided Nanoparticle-Directed Focal Therapy for Prostate Ablation35
Role of Antimuscarinics Combined With Alpha-blockers in the Management of Urinary Storage Symptoms in Patients With Benign Prostatic Hyperplasia: An Updated Systematic Review and Meta-analysis. Letter35
Effect of Cannabidiol Oil on Post-ureteroscopy Pain for Urinary Calculi: A Randomized, Double-blind, Placebo-controlled Trial. Letter.35
Letter: Intraoperative Tranexamic Acid in Radical Cystectomy: Impact on Bleeding, Thromboembolism, and Survival Outcomes35
An Algorithm to Personalize Nerve Sparing in Men with Unilateral High-Risk Prostate Cancer34
Reply by Authors34
Effectiveness of Liposomal Bupivacaine With Bupivacaine Hydrochloride vs Bupivacaine Hydrochloride Alone as a Local Anesthetic for Children Undergoing Ambulatory Urologic Surgery: The Baby ORIOLES Ran33
Safety and Efficacy of Robot-Assisted Laparoscopic Pyeloplasty Compared to Open Repair in Infants under 1 Year of Age33
Early Experience With Pediatric Single-port Robotic Pyeloplasty Compared to Multiport Robotic Cohorts. Reply.32
Fear and Frustration among Women with Recurrent Urinary Tract Infections: Findings from Patient Focus Groups32
Con: Magnetic Resonance Imaging Targeting Leads to Overtreatment of Prostate Cancer32
Comparing Patient-reported Functional Outcomes After Radical Prostatectomy in Historical and Contemporary Practice32
Circumcision and Risk of HIV among Males from Ontario, Canada32
Evaluating the Effectiveness of Artificial Intelligence–powered Large Language Models Application in Disseminating Appropriate and Readable Health Information in Urology. Reply.31
Diversity, Equity & Inclusion: Health Equity & Outcomes II (PD20)31
Primary Chemoablation for Intermediate-risk Low-grade Bladder Cancer: New Paradigm or Added Uncertainty?31
MP17-14 IDENTIFYING CRIBRIFORM PATTERN IN MPMRI SCANS FROM 3D RECONSTRUCTED RALP SPECIMENS USING DEEP LEARNING31
Reply by Authors30
Editorial Comment30
Editorial Comment30
Antimicrobial Prophylaxis in Transurethral Resection of the Prostate: Results of a Randomized Trial30
Reply by Authors30
PD34-11 PROSTATE-SPECIFIC ANTIGEN KINETICS IN PATIENTS WITH ADVANCED PROSTATE CANCER TREATED WITH APALUTAMIDE: RESULTS FROM THE TITAN AND SPARTAN STUDIES30
Reply by Author29
Reply by Authors29
Letter: Urologic Chronic Pelvic Pain Syndrome Flares: A Comprehensive, Systematic Review and Meta-analysis of the Peer-reviewed Flare Literature29
Reply by Authors28
Reply: Prospective Multicenter Evaluation of Pain Before and After Removal of Nonobstructing Renal Calculi: A CoRE Initiative28
Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy Is Prognostic But Not Therapeutic. Letter.28
Editorial Comment28
Editorial Comment28
Editorial Comment27
V04-01 NOVEL UTILIZATION OF INDOCYANINE GREEN TO ASSESS BLADDER PLATE AND PENILE PERFUSION DURING BLADDER EXSTROPHY CLOSURE27
Pathological and Clinical Outcomes in a Large Surveillance and Intervention Cohort of Radiographically Cystic Renal Masses. Letter.27
MP27-09 OXYMATRINE IMPROVES ERECTILE FUNCTION THROUGH SUPPRESSION OF INFLAMMATION AND FIBROSIS IN DIABETIC RATS26
Prostate Cancer: Epidemiology & Natural History II (MP77)26
Education Research I (MP25)25
Sexual Function/Dysfunction: Basic Research & Pathophysiology (MP27)25
MP27-10 CRISPRA-ENGINEERED ADIPOSE-DERIVED STEM CELLS IMPROVE ERECTILE DYSFUNCTION IN DIABETIC RATS25
Editorial Comment24
Editorial Comment24
Editorial Comment24
Reply by Authors24
Female Sexual Function following Sling Surgery: A Prospective Parallel Cohort, Multi-Center Study of the Solyx™ Single Incision Sling System versus the Obtryx™ II Sling System24
Letter: Treatment of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer with UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection of Bladder Tumor Monother23
Editorial Comment23
Editorial Comment23
Editorial Comment23
Editorial Comment23
PD39-11 REDO FOCAL THERAPY FOR RECURRENT LOCALIZED PROSTATE CANCER: A SINGLE INSTITUTION EXPERIENCE22
MP42-09 FACTORS INFLUENCING DECISION MAKING DURING IN VITRO FERTILIZATION AMONG REPRODUCTIVE-AGED MALES22
Prostate Cancer: Advanced (including Drug Therapy) II (MP14)22
MP67-10 15-YEAR FOLLOW-UP OF ONCOLOGIC AND RENAL FUNCTION OUTCOMES: RADIOFREQUENCY ABLATION OF RENAL TUMORS 3-7 CM USING FIBEROPTIC, NON-CONDUCTING TEMPERATURE MONITORING22
MP14-15 WHICH IS THE OPTIMAL MULTIMODAL MANAGEMENT OF PN1 PATIENTS WITH PSA PERSISTENCE AFTER RADICAL PROSTATECTOMY AND EXTENDED NODAL DISSECTION? RESULTS OF A LARGE, MULTI-INSTITUTIONAL DATABASE22
MP45-07 STONE FORMERS WITH HIGHER URIC ACID STONE COMPOSITION AND ELEVATED NLR HAVE AN INCREASED RISK OF CKD21
PD28-06 THE EFFECT OF COMBINATION TREATMENT WITH LOW-INTENSITY SHOCKWAVE THERAPY AND DAILY LOW-DOSE TADALAFIL ON SEVERE ERECTILE DYSFUNCTION: A DOUBLE-BLIND, RANDOMIZED, SHAM-CONTROLLED CLINICAL TRIAL21
Bladder Cancer: Invasive VI (MP77)21
MP65-16 NITROXOLINE SUPPRESSES METASTASIS IN BLADDER CANCER VIA EGR1/circNDRG1/miR-520h/SMAD7/EMT SIGNALING PATHWAY21
MP64-01 GENITOURINARY AND SEXUAL WELLBEING-RELATED PATIENT REPORTED OUTCOME MEASURES USED IN GENDER-AFFIRMING CARE: AN ANALYSIS OF READABILITY, COMPREHENSIVENESS AND APPROPRIATENESS20
V03-02 FROM CT TO 3D: KIDNEY MODEL CREATION 10120
V07-01 PENILE FRACTURE AND ASSOCIATED URETHRAL INJURY20
MP11-06 GENDER DISPARITIES IN FOURNIER'S GANGRENE MORTALITY: INSIGHTS FROM NATIONAL INPATIENT SAMPLE DATA20
V10-08 PERINEAL VAGINOPLASTY AFTER VULVOPLASTY20
PD59-01 OUTCOMES OF SEQUENTIAL THIRD-LINE THERAPIES IN PATIENTS WITH REFRACTORY OVERACTIVE BLADDER20
PD57-09 ADJUVANT OR EARLY SALVAGE RADIOTHERAPY IN NODE POSITIVE PROSTATE CANCER PATIENTS: DEVELOPMENT OF A NOVEL RISK SCORE TO IDENTIFY THE OPTIMAL CANDIDATE FOR EARLY INTENSIFICATION APPROACHES BASED20
PD24-12 BARRIERS TO PERI- AND POST-MENOPAUSAL WOMEN USING VAGINAL ESTROGEN THERAPY INCLUDE COST AND FEAR OF SIDE EFFECTS20
MP52-02 COMBINING STANDARDIZED UPTAKE VALUE OF 18 F-PSMA PET/CT AND APPARENT DIFFUSION COEFFICIENT OF MRI PREDICTS PATHOLOGICAL UPGRADING FROM TARGETED BIOPSY TO RAD20
V14-08 ROBOTIC-ASSISTED LAPAROSCOPIC ANATROPHIC PARTIAL NEPHRECTOMY FOR MANAGEMENT OF A COMPLETELY ENDOPHYTIC RENAL MASS19
MP19-07 TOWARDS A TAILORED USE OF PSA DENSITY TO DECIDE WHEN TO AVOID PROSTATE BIOPSY IN MEN WITH PIRADS 3 LESIONS ACCORDING TO THE LOCATION OF THE INDEX LESION AT MP-MRI. RESULTS OF A LARGE, MULTI-IN19
PD09-07 SPATIAL TRANSCRIPTOMIC SIGNATURE FROM MUTATED BENIGN ANCESTRAL CLONE PREDICTS HIGH RISK PROSTATE CANCER19
MP66-10 DEVELOPMENT AND EVALUATION OF A NOVEL PENILE BLOOD OXYGEN SENSOR FOR ASSESSING TISSUE OXYGENATION19
MP34-05 IT'S NOT JUST MONEY: RACIAL DISPARITIES IN USE OF IN VITRO FERTILIZATION PERSIST REGARDLESS OF STATE HEALTH INSURANCE MANDATES19
MP69-06 THE OPERATIONAL BURDEN IN THE MANAGEMENT OF UTIS IN AN OUTPATIENT ACADEMIC PRACTICE19
MP53-05 IS PDL1 EXPRESSION INDUCED BY PREOPERATIVE CHEMOTHERAPY FOR MUSCLE LAYER INVASIVE BLADDER CANCER?19
MP45-13 RETROSPECTIVE EVALUATION OF PATIENTS UNDERGOING KIDneySeq TM GENETIC TESTING IN THE EVALUATION OF NEPHROLITHIASIS AND NEPHROCALCINOSIS19
MP53-04 NEOADJUVANT VERSUS ADJUVANT CHEMOTHERAPY FOR MUSCLE-INVASIVE BLADDER CANCER: A DECISION ANALYSIS19
MP77-01 LONGITUDINAL ASSESSMENT OF PERIOPERATIVE, POSTOPERATIVE AND EARLY HEALTH RELATED QUALITY OF LIFE OUTCOMES: HEAD TO HEAD COMPARISON BETWEEN ILEAL CONDUIT AND PADUA ILEAL NEOBLADDER FROM A SINGL19
Transplant/ Renovascular (V06)18
MP62-10 ENDOSCOPIC ENUCLEATION OF THE PROSTATE WITH THULIUM:YAG LASER (ThuLEP) VERSUS ROBOT-ASSISTED SIMPLE PROSTATECTOMY (RASP) FOR PROSTATES >150 ML: PERIOPERATIVE AND FUNCTIONAL OUTCOMES18
V11-11 HUGO RAS SIMPLE PROSTATECTOMY SEC. MILLIN: STEP BY STEP SURGICAL PROCEDURE AND SET UP IN A THREE ARMS CONFIGURATION18
PD46-09 PRELIMINARY PATIENT DEMOGRAPHICS FROM THE ERECTILE RESTORATION REGISTRY: IT MATTERS18
PD32-02 ERECTILE DYSFUNCTION CRITERIA OF 131,350 PATIENTS AFTER OPEN, LAPAROSCOPIC, AND ROBOTIC RADICAL PROSTATECTOMY17
MP59-07 STRICT GLUCOSE CONTROL AND ELIMINATION OF NLRP3-INDUCED INFLAMMATION PREVENTS DIABETIC BLADDER DYSFUNCTION IN THE FEMALE AKITA MOUSE MODEL17
MP31-07 PROSTATE EXTRACELLULAR VESICLES AND PREDICTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER: A PROSPECTIVE SINGLE-INSTITUTION PILOT STUDY17
MP49-13 INTERCENTER VARIABILITY IN THE ACCURACY OF RISK CALCULATORS BASED ON MRI PARAMETERS: EXTENSIVE EXTERNAL VALIDATION OF 7 CONTEMPORARY RISK CALCULATORS17
MP51-02 METABOLOMIC PROFILES OF METASTATIC RENAL CELL CARCINOMA16
MP02-18 APPROPRIATENESS OF IMAGING FOR LOW-RISK PROSTATE CANCER – REAL WORLD DATA FROM THE PENNSYLVANIA UROLOGIC REGIONAL COLLABORATION (PURC)16
MP21-06 USABILITY TESTING OF THE SET BRAVE GOALS APP, A CONTINENCE GOAL-SELECTION APP FOR CHILDREN WITH SPINA BIFIDA16
MP48-11 RATES OF FEMALE BLADDER DYSFUNCTION FOLLOWING BOARI FLAP URETERAL RECONSTRUCTION16
MP35-18 AGREEMENT BETWEEN TRANSURETHRAL RESECTION OF BLADDER TUMOR (TURBT) AND RADICAL CYSTECTOMY (RC) PATHOLOGY IN PATIENTS WITH BLADDER CANCER SUBTYPE HISTOLOGY16
V12-09 INGUINAL RECONSTRUCTION AFTER LYMPHADENECTOMY IN METASTATIC PENILE CANCER16
MP08-20 SIGNIFICANT DROP OF EARLY AND TWO-YR MORTALITY FOR BLADDER CANCER PATIENTS RECEIVING RADICAL CYSTECTOMY IN THE LAST 20 YEARS: SINGLE CENTER ANALYSIS16
PD04-02 EFFECTS OF ALPHA BLOCKERS ON HYDRONEPHROSIS AND RENAL FUNCTION IN PATIENTS WITH POSTERIOR URETHRAL VALVES15
PD24-03 PERI- AND POSTOPERATIVE COMPLICATIONS IN ABDOMINAL, VAGINAL EXTRAPERITONEAL AND VAGINAL INTRAPERITONEAL COLPOPEXY15
MP23-19 TREATMENT OF URGE INCONTINENCE IN POSTMENOPAUSAL WOMEN: A SYSTEMATIC REVIEW15
MP29-02 ENDOSCOPIC COMBINED INTRARENAL SURGERY (ECIRS) IS ASSOCIATED WITH A LOWER SECONDARY PUNCTURE RATE WHEN COMPARED TO STANDARD SUPINE PERCUTANEOUS NEPHROLITHOTOMY (S-PCNL): RESULTS FROM A PROPENS15
MP75-02 CAUSAL RELATIONSHIP BETWEEN LOWER URINARY TRACT SYMPTOMS AND FRAILTY: THE CHICKEN OR THE EGG DILEMMA15
MP56-15 CLINICAL CHARACTERISTICS OF PATIENTS WITH RENAL CANCER DO IMPACT MORE THAN ISCHEMIA TIME ON POST-OPERATIVE RENAL FUNCTION15
PD41-07 ASSESSMENT OF THE DIAGNOSTIC ACCURACY OF ONCURIA-DETECT ® FOR DETECTION OF UPPER TRACT UROTHELIAL CARCINOMA15
PD36-08 ARTIFICIAL INTELLIGENCE-BASED SURGICAL PHASE RECOGNITION IN ROBOT-ASSISTED RADICAL PROSTATECTOMY AND CROSS-SURGEON EXTERNAL VALIDITY VERIFICATION15
MP22-13 FRAILTY ADAPTED ERAS PATHWAY FOR PATIENTS WITH BLADDER CANCER REQUIRING SURGERY: THE GLOBAL RADICAL CYSTECTOMY EVALUATION AND MANAGEMENT (GRACEM) STUDY PROTOCOL14
PD43-08 SERUM SEROTONIN LEVELS AS a POTENTIAL RISK FACTOR FOR OVERACTIVE BLADDER IN A COMMUNITY-DWELLING POPULATION: A 4-YEAR LONGITUDINAL STUDY14
PD49-07 UTILITY OF TESTICULAR SHEAR-WAVE ELASTOGRAPHY IN THE EVALUATION OF PEDIATRIC PATIENTS WITH KLINEFELTER SYNDROME14
MP43-19 NOVEL NANOPARTICLE COATINGS DEMONSTRATE ANTIBACTERIAL AND ANTIBIOFILM PROPERTIES AGAINST MULTIPLE UROPATHOGENS14
MP70-16 FEMALES WITH BLADDER CANCER ARE UNDERREPRESENTED IN CLINICAL TRIALS IN THE UNITED STATES14
MP18-02 DOES DEEP LEARNING RECONSTRUCTION IMPROVE URETERAL STONE DETECTION AND SUBJECTIVE IMAGE QUALITY IN THE CT IMAGES OF PATIENTS WITH METAL HARDWARE?14
MP34-11 UNVEILING HIDDEN BIASES IN PAIN MANAGEMENT FOR NEPHROLITHIASIS14
MP22-12 PROSPECTIVE EVALUATION OF OBJECTIVE VS. SUBJECTIVE GRADING OF COMPLICATIONS AFTER RADICAL CYSTECTOMY14
PD60-09 CHIEF RESIDENT PERFORMANCE IN PEDIATRIC UROLOGY: DO EXPECTATIONS AND REALITY ALIGN?14
MP75-09 HOW NOCTURIA CAN HELP A UROLOGIST DIAGNOSE A SLEEP DISORDER14
MP18-12 PREOPERATIVE MRI ANATOMICAL PREDICTORS OF EARLY CONTINENCE AFTER SINGLE-PORT TRANSVESICAL ROBOT-ASSISTED RADICAL PROSTATECTOMY14
MP56-08 TREATMENT AFTER RENAL MASS THERMAL ABLATION TREATMENT FAILURE13
PD47-01 PURE RCT 1: CLINICAL AND COST-EFFECTIVENESS OF FLEXIBLE URETERORENOSCOPY AND EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY FOR LOWER POLE STONES ≤10 MM13
MP36-11 GERIATRIC NUTRITIONAL RISK INDEX AS A SIGNIFICANT PROGNOSTIC FACTOR IN PATIENTS WITH CLEAR-CELL RENAL CELL CARCINOMA13
Prostate Cancer: Staging I (PD17)13
MP62-16 THE UTILITY OF URODYNAMIC STUDIES IN PREDICTING VOIDING FUNCTION IN CATHETER-DEPENDENT PATIENTS AFTER HOLEP: A RETROSPECTIVE STUDY AT A TERTIARY CARE CENTER13
MP54-07 ACADEMIC UROLOGY ENDOWMENTS AND LEADERSHIP ROLES ARE DISPROPORTIONATELY HELD BY MALE UROLOGISTS13
PD20-11 NEOADJUVANT TORIPALIMAB AND CHEMOTHERAPY FOR LOCALLY ADVANCED UPPER URINARY TRACT CARCINOMA: A PILOT STUDY FOR A PHASE II TRIAL13
PD43-06 METHODOLOGY TO ESTABLISH NON-INVASIVE SYNCHRONOUS HEART RATE AND HEART RATE VARIABILITY MEASUREMENT DURING UROFLOWMETRY TO EXAMINE ASSOCIATIONS BETWEEN CARDIOVASCULAR DISEASE AND LOWER URINARY13
PD30-07 HIGH-GRADE TA NON-MUSCLE INVASIVE BLADDER CANCER DEMONSTRATES HOMOGENEOUS ONCOLOGICAL OUTCOMES REGARDLESS OF EAU 2021 RISK GROUP STRATIFICATION13
MP42-05 EFFECT OF VARICOCELE REPAIR ON PREGNANCY AND LIVE BIRTH RATES IN SEVERE OLIGOSPERMIC PATIENTS UNDERGOING ASSISTED REPRODUCTIVE TECHNOLOGY13
PD43-11 SOCIODEMOGRAPHIC FACTORS AND FRAILTY IMPACT ADVANCED THERAPY UTILIZATION AMONG MEDICARE BENEFICIARIES13
PD28-01 NAVIGATING THE CROSSROADS OF ANDROGENIC-ANABOLIC STEROID USE AND DEPRESSION13
MP11-19 INCIDENCE AND RISK FACTORS FOR POST-OPERATIVE INFECTIONS AFTER ROBOTIC-ASSISTED RADICAL PROSTATECTOMY (RARP) IN A SINGLE LARGE INSTITUTION: EFFECT OF TYPE AND DURATION OF PROPHYLACTIC ANTIBIOT13
MP38-11 SOCIODEMOGRAPHIC FACTORS PREDICTIVE OF LYMPH NODE DISSECTION PERFORMANCE IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMAS13
MP16-17 PHASE I STUDY OF INTRAVESICAL FC-OPTIMIZED ANTI-CD40 AGONIST ANTIBODY 2141-V11 FOR NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) UNRESPONSIVE TO BACILLUS CALMETTE-GUERIN (BCG)13
MP24-18 NATIONAL TRENDS OF MALE URETHROPLASTY PROCEDURES: 2016-201913
PD43-12 A NON-INFERIORITY TRIAL FOR TELEMEDICINE IN THE MANAGEMENT OF OVERACTIVE BLADDER13
MP05-18 AMINO ACID TRANSPORT INHIBITION RESENSITIZES ENZALUTAMIDE-RESISTANT PROSTATE CANCER CELLS TO ENZALUTAMIDE13
PD45-04 DOES DRE ADD VALUE TO THE AUA PROSTATE CANCER RISK STRATIFICATION?12
PD16-03 UNDERSTANDING THE MOLECULAR CHARACTERISTICS AND VULNERABILITIES OF SARCOMATOID/RHABDOID RENAL CELL CARCINOMAS THROUGH INTEGRATIVE HISTOLOGICAL AND SPATIAL GENOMICS APPROACHES12
PD56-12 FEASIBILITY AND EFFICACY OF CONTINUOUS FLOW LOCAL ANESTHETIC PUMPS FOR POST-OPERATIVE ANALGESIA FOLLOWING KIDNEY TRANSPLANTATION12
V02-06 A TECHNIQUE FOR COMBINED ROBOTIC SACROCOLPOPEXY AND VENTRAL MESH RECTOPEXY12
MP78-06 RISK FACTORS FOR READMISSION FOLLOWING URETEROSCOPY AND LASER LITHOTRIPSY FOR STONE DISEASE: MODERN SINGLE CENTER EXPERIENCE12
MP40-14 ESTABLISHING A CONNECTION BETWEEN BIRTHWEIGHT AND NEPHROLITHIASIS AMONG ADULT STONE FORMERS12
PD32-01 PROBABILITY OF DRUG-UNASSISTED ERECTILE FUNCTION RECOVERY AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY IN A CONTEMPORARY SERIES12
MP19-10 ADDITIONAL VALUE OF MRI IN PATIENTS WITH PSA >10 NG/ML AND/OR POSITIVE DRE: IS MRI ALWAYS NEEDED?12
MP17-18 LIVING ON A PRAYER: COMPARING RESIDENT COMPENSATION TO LIVING WAGE ESTIMATES12
Surgical Technology & Simulation: Artificial Intelligence II (PD27)12
MP10-11 A PROPENSITY SCORE-MATCHED ANALYSIS OF OUTCOMES OF NEOADJUVANT AND ADJUVANT SYSTEMIC THERAPY IN HIGH-RISK LOCALIZED RENAL CELL CARCINOMA: IMPACT OF TIMING OF THERAPY AND POSITIVE MARGIN12
PD12-04 SGLT2 INHIBITORS ASSOCIATE WITH OVERACTIVE BLADDER SYMPTOMS12
HF01-18 FORTUNE OF FORESIGHT: THE EVOLUTION OF PEDIATRIC UROLOGY AT BOSTON CHILDREN’S HOSPITAL (BCH)12
MP57-15 OUTCOMES OF VIRTUAL VISITS FOR RENAL MASS CONSULTS12
Prostate Cancer: Markers I (MP41)11
MP45-17 REVIEW OF THE SAFETY OF STERILE WATER COMPARED TO NORMAL SALINE AS IRRIGATION SOLUTION IN URETEROSCOPY11
PD28-08 ASSOCIATION OF LOW TESTOSTERONE, FRAILTY, AND POSTOPERATIVE OUTCOMES AMONG MEN UNDERGOING UROLOGIC SURGERY11
V13-10 ROBOTIC SINGLE-PORT TRANSPERINEAL URETHROPLASTY WITH BUCCAL MUCOSA GRAFT11
MP06-10 EFFECT OF INFERIOR ALVEOLAR PLUS BUCCAL NERVE BLOCK ON POSTOPERATIVE MORBIDITY AT BUCCAL MUCOSAL GRAFT HARVEST SITE: A PROSPECTIVE DOUBLE-BLIND RANDOMISED CONTROLLED TRIAL11
PD01-07 NATURAL HISTORY OF PN1 PROSTATE CANCER AFTER RADICAL PROSTATECTOMY: COMPETING RISK ANALYSIS FROM A LARGE MULTI-INSTITUTIONAL SERIES11
PD35-07 IDENTIFYING AND TARGETING UPREGULATED HISTONE MODIFYING ENZYMES INVOLVED IN PROSTATE CANCER CELL SURVIVAL AFTER ANDROGEN DEPRIVATION THERAPY11
V05-06 THE UTILITY OF CYSTOSCOPIC INJECTION OF INDOCYANINE GREEN IN ROBOTIC-ASSISTED PARTIAL CYSTECTOMY11
MP23-12 OPTIMIZING REMOTE ACCESS TO URINARY INCONTINENCE TREATMENTS FOR WOMEN VETERANS: A SEQUENTIAL, MULTIPLE ASSIGNMENT, RANDOMIZED MULTICENTER TRIAL11
PD14-11 THE ANTITUMOR EFFECTS OF INTRAVESICAL THERAPY COMBINED WITH RECOMBINANT BCG AND PEMBROLIZUMAB IN BLADDER CANCER11
MP16-14 A PHASE II TRIAL OF INTRAVESICAL GEMCITABINE AND DOCETAXEL (GEMDOCE) IN THE TREATMENT OF BCG-NAÏVE NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER11
PD36-06 CHARACTERIZING PROSTATE CANCER RISK WITH 68 GA-PSMA-11 PET IMAGING AND AI11
PD55-09 THE BALL IS OUT OF OUR COURT: DOES MODERN PRIMARY CARE LITERATURE REFLECT THE AMERICAN UROLOGICAL ASSOCIATION CRYPTORCHIDISM GUIDELINES?11
MP45-05 PHYSICIAN AND PATIENT ADHERENCE TO KIDNEY STONE PREVENTION GUIDELINES IN A DIVERSE, LOW-RESOURCE, URBAN POPULATION11
Stone Disease: Basic Research & Pathophysiology (MP63)11
HF01-07 THROUGH THE RETROSPECTOSCOPE: CONTRIBUTIONS OF EARLY FEMALE UROLOGISTS11
MP18-20 DEVELOPMENT OF A 3D TUMOR MODEL FUSION PIPELINE FOR RENAL MASS ABLATION: OUTCOMES AND INSIGHTS FROM A HIGH-VOLUME CENTER11
MP34-14 ASSOCIATION OF POPULATION-LEVEL SOCIAL DETERMINANTS OF HEALTH WITH UROLOGIC CANCER CLINICAL TRIALS AVAILABILITY11
MP27-10 MULTICENTER STUDY EVALUATING THE SAFETY AND FEASIBILITY OF TRANSURETHRAL INTRAPROSTATIC INJECTIONS OF ANESTHETICS (TUIA) DELIVERED VIA SCHELIN CATHETER TM TO11
MP02-05 NEXT STOP ON THE ERAS TOUR: REDUCING POST OPERATIVE PAIN AND OPIOID USAGE THROUGH AN ENHANCED RECOVERY PATHWAY FOR PERCUTANEOUS NEPHROLITHOTOMY10
MP38-15 WHAT WILL IT TAKE FOR A URINE BIOMARKER TO REPLACE SURVEILLANCE CYSTOSCOPY FOR INTRAVESICAL RECURRENCE (IVR) AFTER RADICAL NEPHROURETERECTOMY (RNU)10
MP51-18 POPULATION-BASED TRENDS AND OUTCOMES FOR CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA IN THE UNITED STATES10
MP21-17 EXPLORING TRENDS IN UTILIZATION AND COST OF NUCLEAR MEDICINE RENAL SCANS, RENAL ULTRASOUND, AND VOIDING CYSTOURETHROGRAPHY FOR CHILDREN WITH RENAL ANOMALIES USING A NATIONAL CLAIMS DATABASE10
MP49-19 GO WITH THE FLOW: ELUCIDATING RISK FACTORS FOR ACUTE URINARY RETENTION IN PATIENTS UNDERGOING PROSTATE BIOPSY10
MP67-13 BALANCING VTE PREVENTION AND BLEEDING RISK IN PARTIAL NEPHRECTOMY UTILIZING THE CAPRINI SCORE10
PD07-11 NEURO-UROLOGICAL DEVICE BIOFILMS HARBOR UNIQUE MICROBE-METABOLITE INTERACTION NETWORKS IN INFECTED AND UNINFECTED STATES, AND BIOFILM RECONSTITUTION IN VITRO DIFFERS BY BACTERIAL STRAIN AND DE10
PD47-07 THE STUDY OF AUTOMATIC RECOGNITION OF STONE COMPONENTS USING DIGITAL IMAGES FROM INTRAOPERATIVE FLEXIBLE URETEROSCOPY10
MP40-05 MAPPING OF REGISTERED NEPHROLITHIASIS CLINICAL TRIALS10
MP07-04 INITIAL EXPERIENCE WITH A FULLY INTEGRATED ARTIFICIAL INTELLIGENCE PLATFORM DURING MINIMALLY INVASIVE SURGERY10
V12-08 SPECIAL SCENARIOS IN TRANSVESICAL SINGLE-PORT RADICAL PROSTATECTOMY10
MP48-15 ARE KIDNEYS WITH LESS THAN TWENTY PERCENT SPLIT RENAL FUNCTION WORTH RECONSTRUCTING?10
MP36-19 DEVELOPMENT AND VALIDATION OF A NOVEL NOMOGRAM TO PREDICT LYMPH NODE INVASION IN UPPER TRACT UROTHELIAL CARCINOMA10
PD24-06 EXCISION OF PELVIC FLOOR MESH VIA AN ABDOMINAL APPROACH HAS A HIGH SUCCESS RATE AND LONG-TERM PATIENT SATISFACTION10
MP72-02 TRANSVERSE TESTICULAR ECTOPIA AND PERSISTENT MÜLLERIAN DUCT SYNDROME IN PEDIATRIC PATIENTS: MULTICENTRIC SERIES STUDY OF A RARE CONDITION10
V10-02 IMMEDIATE AND LONG-TERM OUTCOMES OF 3-INCISION ARTIFICIAL URINARY SPHINCTER PLACEMENT: CAN A THIRD INCISION REDUCE COMPLICATIONS RELATED TO THE PRESSURE REGULATING BALLOON AND PUMP?10
MP71-12 EVALUATING THE OUTCOMES OF BLADDER-SPARING TREATMENTS (BST) IN PATIENTS WITH BCG-UNRESPONSIVE AND BCG-EXPOSED NMIBC10
PD53-07 INDUCED OBESITY CAUSES STRUCTURAL CHANGES IN THE TESTIS? AN EXPERIMENTAL MODEL10
PD58-02 GENOTYPE-PHENOTYPE ASSOCIATIONS IN VON HIPPEL-LINDAU SYNDROME: IMPLICATIONS FOR SCREENING10
MP62-17 INCREASED OSCILLATION RATE IMPROVES MORCELLATION EFFICIENCY IN HOLMIUM LASER ENUCLEATION OF THE PROSTATE10
MP75-03 ASSOCIATIONS BETWEEN TRAUMATIC LIFE EXPERIENCES AND GENITOURINARY SYMPTOMS10
PD01-10 SALVAGE ROBOTIC RADICAL PROSTATECTOMY FOLLOWING RADIATION VS FOCAL THERAPY10
V12-01 USE OF ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING TO DEVELOP AN EDUCATION SYSTEM FOR INSTRUCTORLESS SURGICAL TRAINING10
MP63-07 THE BUTOX STUDY: THE ROLE OF THE GUT MICROBIOME AND BUTYRATE IN CALCIUM OXALATE KIDNEY STONE DISEASE10
MP05-19 POLYGENETIC RISK SCORE FOR PROSTATE CANCER IS ASSOCIATED WITH LIPOPOLYSACCHARIDE PATHWAY IN GUT MICROBIOME10
PD23-09 THE EFFECT OF ADRENALECTOMY ON OVERALL SURVIVAL IN METASTATIC ADRENOCORTICAL CARCINOMA10
PD44-04 THE EFFECT OF PREOPERATIVE URETERAL STENT ON OUTCOMES OF ROBOTIC PYELOPLASTY FOR URETEROPELVIC JUNCTION OBSTRUCTION: IS URETERAL REST NECESSARY?10
MP07-17 IS AI SEEING WHAT I’M SEEING? VALIDATION OF TOUCH SURGERY’S ENTERPRISE SYSTEM IN CALCULATING WARM ISCHEMIA TIME DURING ROBOTIC-ASSISTED PARTIAL NEPHRECTOMY10
PD36-05 DEEP LEARNING PREDICTIVE MODEL FOR PROSTATE CANCER RECURRENCE USING CLINICAL AND HISTOLOGICAL DATA FROM THE TCGA DATABASE10
MP16-20 FINAL RESULTS OF A PHASE I, SINGLE-ARM CLINICAL TRIAL OF THE COMBINATION OF DURVALUMAB AND VICINEUM IN BCG UNRESPONSIVE, HIGH-RISK NON-MUSCLE-INVASIVE BLADDER CANCER PATIENTS (NCT03258593)10
MP25-04 13-YEAR INTERIM RESULTS FOR TRANSRECTALLY DELIVERED, OUTPATIENT MRI-GUIDED LASER FOCAL THERAPY OF PROSTATE CANCER IN A TREATMENT NAIVE COHORT10
MP61-04 ‘FASCIA LATA FIRST’ APPROACH TO ROBOT-ASSISTED INGUINAL LYMPHADENECTOMY: INITIAL EXPERIENCE AND OUTCOMES10
MP75-15 TIME FROM SURGERY FOR BENIGN PROSTATIC ENLARGEMENT TO SYMPTOMS OF OBSTRUCTION DUE TO THE ONSET OF BLADDER NECK STENOSIS IS ASSOCIATED WITH OUTCOMES AFTER BLADDER NECK INCISION10
V08-06 FEMALE RADICAL CYSTECTOMY AND NEOBLADDER: APICAL DISSECTION WITH URETHRAL AND VAGINAL PREPARATION9
PD33-10 ROBOT-ASSISTED PARTIAL NEPHRECTOMY WITH HUGO™ RAS SYSTEM: PERIOPERATIVE OUTCOMES AND TRIFECTA ACHIEVEMENT FROM THE LARGEST MULTICENTRIC SERIES9
PD06-09 AUGMENTATION CYSTOPLASTY NEGATIVELY IMPACTS EARLY RENAL OUTCOMES IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS9
PD14-02 PATHOLOGICAL ELUCIDATION OF CELLULAR DYNAMICS IN BLADDER CANCER STROMA USING A THREE-DIMENSIONAL COLLAGEN MODEL REPRODUCING CANCER-SPECIFIC MICROENVIRONMENT9
MP26-06 TREATMENT OF URETERAL STENT-RELATED SYMPTOMS WITH A TRANSCUTANEOUS ELECTRICAL NERVE STIMULATOR9
MP05-12 PROTEIN KINASE D1 MITIGATES AGAINST ETOPOSIDE INDUCED DNA DAMAGE THROUGH UP REGULATION OF ALPHA-CATENIN9
0.1675181388855